Federal grant · project grant (b)
Deep Immunophenotyping in Tissue Imaging - Project Summary There Is a Growing Demand for Deep Phenotyping of Single Cells in Tissue, Giving Rise to the Field of Spatial Biology. High Multiplex Imaging Technologies Such as Cyclic Immunofluorescence and Mass Spectrometry Imaging Are Poised to Transform Spatial Biology and Pathology Workflows. However, These Technologies Are Limited by Their Cost, Complexity, and Long Sample-to-result Time. Iterative Fluorescence Approaches Are Limited to 3–6-PLEX Per Round of Staining, Imaging, and De-staining, While Mass Spectrometry Imaging Can Provide ~50 Plex But With Lower Throughput and Much Higher Costs. This Proposal’s Objective Is to Address These Bottlenecks by Significantly Expanding Fluorescence Spectral Multiplexing in Tissue Imaging—the Maximum Number of Protein Markers Per Fluorescence Imaging Cycle—from 3–6 Plex to 56 Plex, by Developing a New Type of Ultrabright Semiconducting Polymer Dot (PDOT) With Simultaneously Narrow Absorption and Emission Bands. We Will Accomplish This Objective via the Following Aims: (1) Develop a 56-COLOR Panel of Pdots With Simultaneously Narrow Absorption and Emission Bands; (2) Demonstrate 56-PLEX Imaging Applied to Immune Profiling of Cells in Tissue Samples and Evaluate Performance; (3) Demonstrate Even Higher Multiplex Imaging (168 Plex) via Cyclic Imaging (with Only 3 Cycles) for Extremely Deep Cell Immuno-phenotyping, Useful in Clinical Discovery and Research Applications. the Narrow-absorption Pdots Will Be Immediately Applicable as They Can Be Used With Existing Commercial Instruments. These Pdots Will Also Enable Spectral Imaging—a New Technology Inspired by Spectral Flow Cytometry, in Which the Full Spectrum of Dye Emission Is Collected to Better Distinguish Dyes and Facilitate Higher Multiplexing. the Proposed Project Is Significant Because It Addresses the Need for Detecting Tens to Hundreds of Protein Markers in Tissue Samples in a Simple, Timely, and Affordable Manner.
Committed
$1.7 Million
Paid out
$639.0K
38%
Committed, not yet paid
$1.1M
62%
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.